Category Matches
- 0.1 mg
- 1 g
- 1 kg
- 1 kit
- 1 L
- 1 mg
- 1 ml
- 1 MU
- 1 Plate
- 1 µg
- 10 g
- 10 mg
- 10 ml
- 10 µg
- 100 g
- 100 mg
- 100 mh
- 100 ml
- 100 Tests
- 100 µg
- 100-200 Tests
- 1000 g
- 100g
- 11β-HSD Inhibitor
- 125 mg
- 125 Tests
- 1mg
- 5 x 100 µg
- 5-HT1 Receptors - Analgesics
- 5-HT1 Receptors - Antidepressant
- 5-HT1 Receptors - Antipsychotic
- 5-HT1 Receptors - Anxiolytic
- 5-HT1 Receptors - Cognition Enhancing
- 5-HT1 Receptors - Hypnotics
- 5-HT1 Receptors - Sedatives
- 50-100 Tests
- ACP-196
- ACP196
- adu-s100
- adus100
- Aldosterone Antagonists - Antihypertensive
- Antihypertensive
- AT-7519
- AT7519
- AZ-5104
- AZ5104
- AZD-1152
- AZD-1152-HQPA
- AZD-1208
- AZD-8186
- AZD-9291
- BACE1
- BAY1816032
- BIX01294
- BUB1
- BYL719
- Ca2+ Channel Blockers - Antihypertensive
- CEP-28122
- chemicals for COVID-19 research
- CHIR99021
- Chk1/2
- COVID-19
- covid-19
- COVID-19 chemicals
- COVID-19 compounds
- COX-1 - Analgesics
- CYP17A1 Inhibitors
- D1 Receptors - Analgesics
- D1 Receptors - Anesthetic
- D1 Receptors - Antidepressant
- D1 Receptors - Antipsychotic
- D1 Receptors - Anxiolytic
- D1 Receptors - Cognition Enhancing
- D1 Receptors - Neurodegenerative Diseases
- D1 Receptors - Sedatives
- DOT1L Histone Methyltransferase
- eidd-1931
- EIDD-2801
- EIDD2801
- GBR-12935
- GDC-0941
- GLP-1 Agonists
- HEXIM1
- HIF-1
- IGF-1R
- JQ-1
- JQ-1
- KNL1
- LOXO-195
- loxo195
- NKCC1 Inhibitors (Loop Diuretics)
- NSAIDs: COX-1 Inhibitors
- OTX-015
- p110
- p110alpha
- P2Y12
- PDK1
- PF-07321332
- Pim-1
- Pim1
- PKC412
- Rac1
- RAD51
- rated-1
- RN-1734
- ROS1
- SB-431542
- ser910
- su9516
- T315i
- TAE684
- TAK-931
- UNC0064-12
- VE821
- α1-adrenergic Receptor Antagonists - Antihypertensive
- α1-adrenergic Receptor Antagonists - Vasodilatory
Product Matches
- A9617Azelnidipine
Dihydropyridine; L-type Ca2+ channel blocker.
≥98% - P2818Phentolamine Methanesulfonate
ATP-sensitive K+ channel activator, α-adrenergic antagonist.
≥98% - P2817Phentolamine Hydrochloride
ATP-sensitive K+ channel activator, α-adrenergic antagonist.
≥98% - N3228Nifedipine
Dihydropyridine; L-type Ca2+ channel blocker.
≥98% - V1769Verapamil Hydrochloride
L-type Ca2+ channel blocker.
≥98% - D5690Doxazosin Mesylate
Quinazoline; α1-adrenergic antagonist.
≥98% - F1745Felodipine
Dihydropyridine; L-type Ca2+ channel blocker.
≥98% - A5044Amlodipine Besylate
Dihydropyridine, FIASMA; L-type Ca2+ channel blocker.
≥98% - N3208Nicardipine
Dihydropyridine; L-type Ca2+ channel blocker.
≥99% - A5045Amlodipine
Dihydropyridine, FIASMA; L-type Ca2+ channel blocker.
≥98% - U6802Urapidil Hydrochloride
5-HT1A agonist, α1-adrenergic antagonist.
≥98% - U6801Urapidil
5-HT1A agonist, α1-adrenergic antagonist.
≥98% - M0248Manidipine Dihydrochloride
Dihydropyridine; L-type and T-type Ca2+ channel blocker.
≥99% - T1670Terazosin Hydrochloride Dihydrate
Quinazoline; α1-adrenergic antagonist.
≥98% - C3446Cilnidipine
Dihydropyridine; L-type and N-type Ca2+ channel blocker.
≥98% - N3448Nimodipine
L-type Ca2+ channel blocker.
≥98% - B1752Benidipine Hydrochloride
Calcium channel blocker.
≥98% - N3478Nitrendipine
Calcium channel blocker.
≥98% - I7468Isradipine
Calcium channel blocker.
≥98% - N3474Nisoldipine
Calcium channel blocker.
≥98%